Health AI Central
Peer-Reviewed Publication
Am J Prev Cardiol2027;31101780.January 1, 2027Journal Article

Retinal AI risk stratification and cardiovascular event yield across QRISK3 categories in UK Biobank.

Sahil Thakur1,2, Jaewon Seo1, Zahra Darmani3, Dongjin Nam4, Husain Khaki5, Simon Nusinovici2, Tyler Hyungtaek Rim1,2
1Mediwhale Inc. Seoul, South Korea.
2Duke NUS Medical School, Singapore.
3Al-Farabi Kazakh National University, Almaty, Kazakhstan.
4Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
5Heart Eye Diagnostics Limited, London, United Kingdom.
PubMed PMC DOI PDF

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.